Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Why Farber Disease May Be Misdiagnosed as Juvenile Idiopathic Arthritis

Boris Hugle, MD, MSc, Laura Mueller & Thierry Levade, MD, PhD  |  June 1, 2014

A case study reveals how late presentation of this rare, autosomal-recessive disorder, which can involve arthritis-like symptoms, can be mistaken for JIA

Filed under:ConditionsRheumatoid Arthritis Tagged with:Juvenile idiopathic arthritisMethotrexatepatient careRheumatoid arthritisrheumatologist

Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection

Simon M. Helfgott, MD  |  May 1, 2014

How method of diagnosing, treating this inflammatory back disease characterized by stiffness and the presence of HLA-B27 gene has evolved

Filed under:Axial SpondyloarthritisConditionsOpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:Ankylosing Spondylitisanti-inflammatorygeriatricsPainpatient careResearchrheumatologistrheumatologyTreatment

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  April 2, 2014

Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesOsteoarthritis and Bone DisordersRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:BiologicsdrugDrug SafetyMethotrexateOsteoporosisRheumatoid arthritisrheumatologySafetySystemic lupus erythematosus

Therapeutic Value of Colchicine in Osteoarthritis, Cardiovascular Disease Explored at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

Drug’s antiinflammatory properties may help alleviate pain in patients with OA, reduce risk of myocardial infarction, but toxicity, drug interactions need to be considered

Filed under:ConditionsDrug UpdatesGout and Crystalline ArthritisMeeting ReportsOsteoarthritis and Bone Disorders Tagged with:AC&RAmerican College of Rheumatology (ACR)anti-inflammatoryCardiovascular diseaseColchicinecrystal arthritisGoutimagingOsteoarthritispatient carerheumatology symposium

Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff  |  April 2, 2014

By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine

Filed under:ConditionsDrug UpdatesMeeting ReportsOsteoarthritis and Bone DisordersOther Rheumatic ConditionsRheumatoid Arthritis Tagged with:ACR/ARHPAdenosineanti-inflammatorybonedrugMethotrexateOsteoarthritispatient careRheumatoid arthritisrheumatologist

State-of-the-Art Clinical Symposium Scheduled for April 26–27 in Chicago

Staff  |  April 2, 2014

ACR’s education and networking seminar to address latest in therapy, research, and scientific advances in rheumatology

Filed under:Billing/CodingCareer DevelopmentEducation & TrainingFrom the CollegePractice SupportProfessional Topics Tagged with:BillingCodingEducationICD-10Practice Managementrheumatologist

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesOsteoarthritis and Bone DisordersPsoriatic ArthritisRheumatoid Arthritis Tagged with:Ankylosing Spondylitisanti-inflammatoryApprovalsdrugFDAMethotrexateOsteoarthritisPipelinePsoriatic ArthritisRheumatoid arthritisrheumatologistrheumatologySafety

Evolutionary Medicine Provides Insight into the Chronic Inflammatory State Note Rheumatologists at the 2013 ACR/ARHP Annual Meeting

Mary Beth Nierengarten  |  March 1, 2014

Studies on metabolism, neuroendocrinology, and immunology can broaden understanding of the pathophysiology of chronic inflammatory diseases

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsResearch Rheum Tagged with:AC&RACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)ImmunologyInflammatory DiseasemetabolismResearchrheumatology

2014 State-of-the-Art Clinical Symposium to Be Held April 26–27 in Chicago

Staff  |  March 1, 2014

ACR’s education and networking seminar to address latest in research, therapy, and scientific advances in rheumatology

Filed under:Billing/CodingCareer DevelopmentEducation & TrainingFrom the CollegePractice SupportProfessional TopicsResearch Rheum Tagged with:AC&RAmerican College of Rheumatology (ACR)Billingclinical symposiumCodingeducation and trainingICD-10Practice ManagementResearchrheumatology

ACR’s Lupus Initiative Advances Education Around Diagnosing, Treating Disease

Joseph Flood, MD  |  March 1, 2014

Online progam boasts continuing medical education, learning curriculum for healthcare professionals and students, as well as a smartphone app to help patients track their symptoms

Filed under:Career DevelopmentConditionsEducation & TrainingLegislation & AdvocacyPresident's PerspectiveProfessional TopicsSystemic Lupus Erythematosus Tagged with:AC&RACR Lupus InitiativeAdvocacyAmerican College of Rheumatology (ACR)continuing medical educationeducation and trainingLupuspatient carerheumatologistSystemic lupus erythematosus

  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 125
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences